CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,538,021 | -30.7% | 116,263 | +0.9% | 0.02% | -34.4% |
| Q2 2023 | $3,664,719 | +45.6% | 115,279 | +11.7% | 0.03% | +45.5% |
| Q1 2023 | $2,517,292 | -24.8% | 103,210 | -2.7% | 0.02% | -26.7% |
| Q4 2022 | $3,345,322 | +39.3% | 106,066 | +24.8% | 0.03% | +30.4% |
| Q3 2022 | $2,401,000 | +3.2% | 84,970 | -3.4% | 0.02% | 0.0% |
| Q2 2022 | $2,326,000 | -56.3% | 87,969 | -42.2% | 0.02% | -60.3% |
| Q1 2022 | $5,326,000 | -3.6% | 152,115 | -10.7% | 0.06% | -6.5% |
| Q4 2021 | $5,524,000 | +5.5% | 170,399 | -4.0% | 0.06% | +24.0% |
| Q3 2021 | $5,238,000 | +22.4% | 177,565 | +6.3% | 0.05% | +31.6% |
| Q2 2021 | $4,278,000 | – | 166,983 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,005,284,000 | 38.09% |
| Ally Bridge Group (NY) LLC | 1,767,440 | $29,304,000 | 5.02% |
| Affinity Asset Advisors, LLC | 270,000 | $4,477,000 | 2.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 811,665 | $13,457,000 | 1.19% |
| Artal Group S.A. | 2,282,100 | $37,837,000 | 0.81% |
| Perceptive Advisors | 4,544,062 | $75,340,000 | 0.81% |
| RA Capital Management | 2,200,000 | $36,476,000 | 0.51% |
| Monashee Investment Management LLC | 200,000 | $3,316,000 | 0.44% |
| Boxer Capital, LLC | 714,500 | $11,846,000 | 0.38% |
| EcoR1 Capital, LLC | 400,000 | $6,632,000 | 0.36% |